1-3 of 3
Giovanni Franco
Close
Sort by
Journal Articles

Bone marrow stroma CD40 expression correlates with inflammatory mast cell infiltration and disease progression in splenic marginal zone lymphoma

Giovanni Franco, Carla Guarnotta, Barbara Frossi, Pier Paolo Piccaluga, Emanuela Boveri, Alessandro Gulino, Fabio Fuligni, Alice Rigoni, Rossana Porcasi, Salvatore Buffa, Elena Betto, Ada Maria Florena, Vito Franco, Emilio Iannitto, Luca Arcaini, Stefano Aldo Pileri, Carlo Pucillo, Mario Paolo Colombo, Sabina Sangaletti, Claudio Tripodo
Journal: Blood
Blood (2014) 123 (12): 1836–1849.
https://doi.org/10.1182/blood-2013-04-497271
Published: 2014
Includes: Supplemental data
Journal Articles

Stromal SPARC contributes to the detrimental fibrotic changes associated with myeloproliferation whereas its deficiency favors myeloid cell expansion

Claudio Tripodo, Sabina Sangaletti, Carla Guarnotta, Pier P. Piccaluga, Matilde Cacciatore, Michela Giuliano, Giovanni Franco, Claudia Chiodoni, Marika Sciandra, Silvia Miotti, Giuseppe Calvaruso, Alessandra Carè, Ada M. Florena, Katia Scotlandi, Attilio Orazi, Stefano A. Pileri, Mario P. Colombo
Journal: Blood
Blood (2012) 120 (17): 3541–3554.
https://doi.org/10.1182/blood-2011-12-398537
Published: 2012
Includes: Supplemental data
Journal Articles

Non-Pegylated Lyposomal Doxorubicin, Cyclophosphamide, Vincristine, Prednisone and Rituximab (R-COMP) as Initial Treatment for Patients with Splenic Marginal Zone Lymphoma (SMZL). A GISL Study

Emilio Iannitto, MD, Stefano Luminari, MD, Caterina Mammi, MD, Viviana Minardi, Francesco Merli, MD, Francesco Angrilli, MD, Caterina Stelitano, MD, Marina Cesaretti, Giovanni Franco, MD, Angelo M. Carella, MD, Massimo Federico, MD
Journal: Blood
Blood (2007) 110 (11): 1293.
https://doi.org/10.1182/blood.V110.11.1293.1293
Published: 2007